Daiichi Sankyo | 4568 - Ebitda


Daiichi Sankyo reported JPY101.6B in EBITDA for its fiscal quarter ending in March of 2025.





Ebitda Change Date
Astellas Pharma JPY 235.24B 136.32B Jun/2026
Chugai Pharma JPY 158.77B 10.24B Mar/2026
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Eisai JPY 34.15B 34.48B Jun/2026
Kyowa Hakko Kirin JPY 53.91B 36.74B Jun/2026
M3 JPY 35.31B 20.26B Jun/2026
Otsuka Holdings JPY 156.66B 56.89B Mar/2026
Shionogi JPY 87.79B 59.04B Jun/2026
Sumitomo Dainippon JPY 1.43B 78.97B Mar/2026
Takeda JPY 364.46B 214.21B Jun/2026
Terumo JPY 116.67B 58.79B Jun/2026